Investigating strategies to improve attendance at screening visits in a randomized trial

av Chen, Fang, Rahimi, K, Haynes, R, Naessens, K, Taylor-Clarke, M, Murray, C, Armitage, Jane
Publicerad 2011

Expression of Stem Cell Markers in Preinvasive Tubal Lesions of Ovarian Carcinoma

av Chene, G., Ouellet, V., Rahimi, K., Barres, V., Meunier, L., De Ladurantaye, M., Provencher, D., Mes-Masson, A. M.
I publikationen Biomed Res Int (2015)

A distinct pre-existing inflammatory tumour microenvironment is associated with chemotherapy resistance in high-grade serous epithelial ovarian cancer

av Koti, M, Siu, A, Clément, I, Bidarimath, M, Turashvili, G, Edwards, A, Rahimi, K, Masson, A-M M, Squire, J A
I publikationen Br J Cancer (2015)

A distinct pre-existing inflammatory tumour microenvironment is associated with chemotherapy resistance in high-grade serous epithelial ovarian cancer

av Koti, M, Siu, A, Clément, I, Bidarimath, M, Turashvili, G, Edwards, A, Rahimi, K, Mes-Masson, A-M, Squire, J A
I publikationen Br J Cancer (2015)

HPS2-THRIVE randomized placebo-controlled trial in 25 673 high-risk patients of ER niacin/laropiprant: trial design, pre-specified muscle and liver outcomes, and reasons for stoppi...

av Haynes, Richard, Jiang, Lixin, Hopewell, Jemma C, Li, Jing, Chen, Fang, Parish, Sarah, Landray, Martin J., Collins, Rory, Armitage, Jane, Collins, R., Armitage, J., Baigent, C., Chen, Z., Landray, M., Chen, Y., Jiang, L., Pedersen, T., Landray, M., Bowman, L., Chen, F., Hill, M., Haynes, R., Knott, C., Rahimi, K., Tobert, J., Sleight, P., Simpson, D., Parish, S., Baxter, A., Lay, M., Bray, C., Wincott, E., Leijenhorst, G., Skattebol, A., Moen, G., Mitchel, Y., Kuznetsova, O., MacMahon, S., Kjekshus, J., Hill, C., Lam, T.H., Sandercock, P., Peto, R., Hopewell, J.C.
Publicerad 2013